Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-064138
Filing Date
2025-06-30
Accepted
2025-06-30 16:21:21
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518376-1_3seq1.xml 3 4811
2 EXHIBIT 24 tm2518376d1_ex24.htm EX-24 6631
  Complete submission text file 0001104659-25-064138.txt   12956
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address
Im Ellie Eunkyung (Reporting) CIK: 0002075219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 251092341